Skandinaviska Enskilda Banken Ab (Publ) Fibrogen Inc Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

  • $21.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023
BUY
$2.49 - $20.59 $28,386 - $234,726
11,400 New
11,400 $31,000
Q2 2021

Aug 10, 2021
SELL
$18.57 - $35.68 $317,472 - $609,985
-17,096 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$31.0 - $55.72 $529,976 - $952,589
17,096 New
17,096 $593,000

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $31.9M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email